When pharma-focused mobile clinical trial data collection company Clinical Ink and CentrosHealth, formerly MyHealthBook, which makes configurable mobile apps for clinical trial patient engagement,merged last month, at least $9.8 million in equity and stock was exchanged as part of the merger, according to an SEC filing. According to the filing, some of that money went to the acquired company's...
Pharma-focused mobile clinical trial data collection company Clinical Ink has merged with CentrosHealth, formerly MyHealthBook, which makes configurable mobile apps for clinical trial patient engagement. As part of the deal, MPM Capital, which founded CentrosHealth, will make an additional investment in Clinical Ink, as will F2 Ventures, FCA Venture Partners and other existing Clinical Ink...
Blood pressure centiles, a SMART app.
The SMART platform (Substitutable Medical Apps and Reusable Technology), an ONC-funded, Boston Children's Hospital-led effort to encourage the development of modular apps for EHRs, has announced an advisory committee to help support the growth of the platform.
The committee includes representatives from The Advisory Board Company, AARP, BMJ, Canadian...
